Interventional Oncology Devices Market By Product (Embolization Devices, Ablation Devices, and Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, and Transcatheter Arterial Embolization/Bland Embolization), By Cancer (Liver Cancer, Lung Cancer, Bone Cancer, and Kidney Cancer), and By Region - Trends, Analysis and Forecast till 2030

Market for interventional oncology devices was valued at US$ 4.2 billion in 2025 and is anticipated to grow at a moderate rate of growth over the next several years.

Oncology is the study of cancer diagnosis, prevention, and therapy. An oncologist is a medical professional who practices oncology. Cancer is diagnosed by a variety of ultrasonography or radiological techniques, including endoscopy, biopsy, X-ray, MRI, CT scanning, PET scanning, and others. Compared to traditional open surgeries, interventional device cancer care involves less intrusive techniques, less problems, lower risk of infection, shorter hospital stays, less discomfort, and quicker recovery times.